share_log

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Short Interest Update

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Short Interest Update

EFFECTOR Therapeutics, Inc.(纳斯达克股票代码:EFTRW)空头利
Defense World ·  2023/02/01 02:13

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) saw a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 21,500 shares, an increase of 6.4% from the December 31st total of 20,200 shares. Based on an average trading volume of 14,700 shares, the short-interest ratio is presently 1.5 days.

Effector Therapeutics, Inc.(纳斯达克股票代码:EFTRW — Get Rating)在1月份的空头利率大幅增加。截至1月15日,空头利率共计21,500股,较12月31日的20,200股增长了6.4%。根据14,700股的平均交易量,目前的空头利率为1.5天。

eFFECTOR Therapeutics Trading Down 11.6 %

Effector Therapeutics 交易下跌

Shares of NASDAQ EFTRW opened at $0.14 on Wednesday. The firm's fifty day moving average is $0.14 and its two-hundred day moving average is $0.15. eFFECTOR Therapeutics has a 52-week low of $0.04 and a 52-week high of $0.73.

纳斯达克EFTRW的股价周三开盘价为0.14美元。该公司的五十天移动平均线为0.14美元,其两百天移动平均线为0.15美元。Effector Therapeutics的52周低点为0.04美元,52周高点为0.73美元。

See Also

另见

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
  • Dividend King Sysco: Buying On The Dip
  • Is the 1,600% Rise in Genius Group Stock Justified?
  • After Further Review, Investors Liked Exxon Mobil's Earnings
  • Will Caterpillar Dig Its Way To Another Buying Opportunity?
  • 免费获取 StockNews.com 关于 Effector Therapeutics(EFTRW)的研究报告
  • Verizon、Charter在过去一个月中呈上升趋势:他们现在买了吗?
  • 股息之王 Sysco:逢低买入
  • Genius集团股票上涨1,600%是否合理?
  • 经过进一步审查,投资者喜欢埃克森美孚的收益
  • 卡特彼勒会挖掘另一个买入机会吗?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Effector Therapeutics 的新闻 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Effector Therapeutics及相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发